Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Abstract: The invention provides a means for a treatment for a demyelinating disease of the central nervous system (CNS) characterized by the presence of an anti-myelin oligodendrocyte glycoprotein (MOG) antibody, and also for reducing the risk of relapse in the demyelinating disease, comprising an anti-IL-6 receptor antibody or antigen binding fragment thereof.

Abstract: An electro-optic media includes either a plurality of microcapsules in a binder, a polymeric sheet containing sealed microcells, or droplets in a continuous polymeric phase. Each of the microcapsules, microcells, or droplets contain a dispersion that includes a plurality of charged composite particles and a suspending fluid, and the charged particles move through the suspending fluid under the influence of an electric field. The composite particles include one or more types of pigment particles that are at least partially coated with a polymeric material. Each of the binder, polymeric sheet, continuous polymeric phase, the charged composite particles, and the suspending fluid have an index of refraction, and a difference between the index of refraction of the composite particles and at least one of the binder, polymeric sheet, continuous polymeric phase, and solvent is less than or equal to 0.05 at 550 nm.

Abstract: The present disclosure provides pharmaceutical compositions for treating or preventing myasthenia gravis comprising satralizumab as an active ingredient.

Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Abstract: A variable transmission film may include an electrophoretic medium having a plurality of capsules and a binder, each capsule containing a plurality of electrically charged particles and a fluid, the charged particles being movable by application of an electric field and being capable of being switched between an open state and a closed state. The film may include at least one of a binder containing fish gelatin and a polyanion; a binder containing one or more tinting agents; capsules containing charge control agents, such as an oligoamine-terminated polyolefin and a branched chain fatty acid comprising at least 8 carbon atoms; a selection of capsules in which at least 60% have a diameter between 50 ?m and 90 ?m and at least 15% have a diameter between 20 ?m and 49 ?m; a tinted adhesive layer; and a fluid selected from one or more nonconjugated olefinic hydrocarbons.

Abstract: A variable transmission film may include an electrophoretic medium having a plurality of capsules and a binder, each capsule containing a plurality of electrically charged particles and a fluid, the charged particles being movable by application of an electric field and being capable of being switched between an open state and a closed state. The film may include at least one of a binder containing fish gelatin and a polyanion; a binder containing one or more tinting agents; capsules containing charge control agents, such as an oligoamine-terminated polyolefin and a branched chain fatty acid comprising at least 8 carbon atoms; a selection of capsules in which at least 60% have a diameter between 50 ?m and 90 ?m and at least 15% have a diameter between 20 ?m and 49 ?m; a tinted adhesive layer; and a fluid selected from one or more nonconjugated olefinic hydrocarbons.

Abstract: An electro-optic media includes either a plurality of microcapsules in a binder, a polymeric sheet containing sealed microcells, or droplets in a continuous polymeric phase. Each of the microcapsules, microcells, or droplets contain a dispersion that includes a plurality of charged composite particles and a suspending fluid, and the charged particles move through the suspending fluid under the influence of an electric field. The composite particles include one or more types of pigment particles that are at least partially coated with a polymeric material. Each of the binder, polymeric sheet, continuous polymeric phase, the charged composite particles, and the suspending fluid have an index of refraction, and a difference between the index of refraction of the composite particles and at least one of the binder, polymeric sheet, continuous polymeric phase, and solvent is less than or equal to 0.05 at 550 nm.

Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Abstract: An electro-optic media includes either a plurality of microcapsules in a binder, a polymeric sheet containing sealed microcells, or droplets in a continuous polymeric phase. Each of the microcapsules, microcells, or droplets contain a dispersion that includes a plurality of charged composite particles and a suspending fluid, and the charged particles move through the suspending fluid under the influence of an electric field. The composite particles include one or more types of pigment particles that are at least partially coated with a polymeric material. Each of the binder, polymeric sheet, continuous polymeric phase, the charged composite particles, and the suspending fluid have an index of refraction, and a difference between the index of refraction of the composite particles and at least one of the binder, polymeric sheet, continuous polymeric phase, and solvent is less than or equal to 0.05 at 550 nm.

Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Abstract: A variable transmission film may include an electrophoretic medium having a plurality of capsules and a binder, each capsule containing a plurality of electrically charged particles and a fluid, the charged particles being movable by application of an electric field and being capable of being switched between an open state and a closed state. The film may include at least one of a binder containing fish gelatin and a polyanion; a binder containing one or more tinting agents; capsules containing charge control agents, such as an oligoamine-terminated polyolefin and a branched chain fatty acid comprising at least 8 carbon atoms; a selection of capsules in which at least 60% have a diameter between 50 ?m and 90 ?m and at least 15% have a diameter between 20 ?m and 49 ?m; a tinted adhesive layer; and a fluid selected from one or more nonconjugated olefinic hydrocarbons.

Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Abstract: A variable transmission film may include an electrophoretic medium having a plurality of capsules and a binder, each capsule containing a plurality of electrically charged particles and a fluid, the charged particles being movable by application of an electric field and being capable of being switched between an open state and a closed state. The film may include at least one of a binder containing fish gelatin and a polyanion; a binder containing one or more tinting agents; capsules containing charge control agents, such as an oligoamine-terminated polyolefin and a branched chain fatty acid comprising at least 8 carbon atoms; a selection of capsules in which at least 60% have a diameter between 50 ?m and 90 ?m and at least 15% have a diameter between 20 ?m and 49 ?m; a tinted adhesive layer; and a fluid selected from one or more nonconjugated olefinic hydrocarbons.

Abstract: An electro-optic media includes either a plurality of microcapsules in a binder, a polymeric sheet containing sealed microcells, or droplets in a continuous polymeric phase. Each of the microcapsules, microcells, or droplets contain a dispersion that includes a plurality of charged composite particles and a suspending fluid, and the charged particles move through the suspending fluid under the influence of an electric field. The composite particles include one or more types of pigment particles that are at least partially coated with a polymeric material. Each of the binder, polymeric sheet, continuous polymeric phase, the charged composite particles, and the suspending fluid have an index of refraction, and a difference between the index of refraction of the composite particles and at least one of the binder, polymeric sheet, continuous polymeric phase, and solvent is less than or equal to 0.05 at 550 nm.

Abstract: Methods of treating Alzheimer's Disease (AD) in patients suffering from early AD, including amyloid positive patients, ApoE4 positive patients, and patients suffering from prodromal or mild AD are provided.

Abstract: A variable transmission film may include an electrophoretic medium having a plurality of capsules and a binder, each capsule containing a plurality of electrically charged particles and a fluid, the charged particles being movable by application of an electric field and being capable of being switched between an open state and a closed state. The film may include at least one of a binder containing fish gelatin and a polyanion; a binder containing one or more tinting agents; capsules containing charge control agents, such as an oligoamine-terminated polyolefin and a branched chain fatty acid comprising at least 8 carbon atoms; a selection of capsules in which at least 60% have a diameter between 50 ?m and 90 ?m and at least 15% have a diameter between 20 ?m and 49 ?m; a tinted adhesive layer; and a fluid selected from one or more nonconjugated olefinic hydrocarbons.